Parkside Financial Bank & Trust boosted its position in shares of Clorox Company (The) (NYSE:CLX) by 3.8% during the second quarter, Holdings Channel reports. The firm owned 796 shares of the company’s stock after buying an additional 29 shares during the period. Parkside Financial Bank & Trust’s holdings in Clorox Company (The) were worth $107,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. American Beacon Advisors Inc. purchased a new position in Clorox Company (The) during the first quarter worth approximately $104,000. Quadrant Capital Group LLC raised its position in Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock worth $106,000 after buying an additional 158 shares during the period. Valley National Advisers Inc. raised its position in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. raised its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation raised its position in Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at 134.21 on Thursday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a market capitalization of $17.29 billion, a P/E ratio of 26.51 and a beta of 0.40. The company’s 50 day moving average is $133.88 and its 200-day moving average is $133.46.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the company posted $1.30 EPS. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.68 EPS for the current year.

WARNING: This piece of content was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/08/10/clorox-company-the-clx-position-boosted-by-parkside-financial-bank-trust.html.

A number of research firms have commented on CLX. UBS AG restated a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. Jefferies Group LLC restated a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. BMO Capital Markets set a $150.00 price target on shares of Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Clorox Company (The) presently has a consensus rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.